BWL
UNCY icon

Bogart Wealth LLC’s Unicycive Therapeutics UNCY Stock Holding History

Bogart Wealth LLC’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39 Hold
6
– – ﹤0.01% 1779
2025
Q4 		$35 Hold
6
– – ﹤0.01% 1571
2025
Q3 		$26 Hold
6
– – ﹤0.01% 1521
2025
Q2 		$29 Hold
6
– – ﹤0.01% 1440
2025
Q1 		$34 Hold
6
– – ﹤0.01% 1391
2024
Q4 		$48 Buy
+6
New +$33 ﹤0.01% 1332

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bogart Wealth LLC's UNCY Position: Q1 2026 in Review

Bogart Wealth LLC held its Unicycive Therapeutics (UNCY) position steady in Q1 2026 at 6 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Bogart Wealth LLC first reported a position in UNCY in Q4 2024 and has held it in 6 quarters since. The position peaked at $48 in Q4 2024. 51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

  • Bogart Wealth LLC held 6 shares of Unicycive Therapeutics worth $39 as of Q1 2026.
  • Bogart Wealth LLC left its Unicycive Therapeutics share count unchanged in Q1 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1779 holding.
  • Bogart Wealth LLC first reported a position in Unicycive Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Bogart Wealth LLC's Unicycive Therapeutics position peaked at $48 in Q4 2024.
  • 51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.